Pulmonology Articles

Pulmonology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kao S et al. - The authors report the case of a 27-year-old woman with pleural well-differentiated papillary mesothelioma, who was treated with bilateral pleurodesis and pericardial window to control the production of malignant fluid, without significant systemic anticancer treatment. She survived for 16 years, confirming its indolent nature. This case report also highlights the role of fluid cytology, immunohistochemistry, and electron microscopy in the diagnosis of well-differentiated papillary mesothelioma and the potential use of serum CA-125 as a marker of progression.

Related Articles

Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature
World Journal of Surgical Oncology, 11/12/09    Relevance Score: 90%%

A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Oncogene, 11/30/09    Relevance Score: 87%%

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Journal of Clinical Oncology, 11/24/09    Relevance Score: 85%%

Molecular Targets in Malignant Pleural Mesothelioma Treatment
Current Drug Targets, 11/10/09    Relevance Score: 84%%

Second-line treatment for malignant pleural mesothelioma
Cancer Treatment Reviews, 11/05/09    Relevance Score: 84%%